Brief: Samsung Pharmaceutical lowers conversion price of 30th series bonds to 3,447 won/share
Aug 21 (Reuters) - Samsung Pharmaceutical Co Ltd 001360.KS
:
* Says it lowered conversion price of 30th series bonds to
3,447 won/share from 3,688 won/share
Source text in Korean: https://goo.gl/QnQKck
Further company coverage: 001360.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on Samsung Pharm
See all newsBrief: Samsung Pharmaceutical Wins 33.5 Billion Won Order
Brief: Samsung Pharmaceutical Says Acquires Shares Worth 12.5 bln Won In True Life Insurance Bank
Brief: Samsung Pharmaceutical To Invest 15.3 Billion Won To Build New Manufacturing Line
Brief: Samsung Pharmaceutical To Sell 8 Bln Won Asset To Samsung Medicos
Brief: Samsung Pharmaceutical Plans 20 Bln Won Investment In S.Korea